AstraZeneca’s CEO Pascal Soriot has finally realized his dream of moving the company to the world-famous bioscience hub of Cambridge, UK, but must now meet raised expectations of success with a next generation of pipeline candidates.
The opening of the Discovery Centre in Cambridge (DISC) on 23 November alongside its corporate headquarters was a long-awaited victory...